A new metasurface spectral AI chip enables rapid, accurate diagnosis of meibomian gland dysfunction (MGD) from tissue samples, achieving 96.22% accuracy.
Key Details
- 1Researchers from Peking Union Medical College Hospital and Tsinghua University developed a compact optical AI chip for MGD diagnosis.
- 2The AI chip integrates a spectral convolutional neural network (SCNN) directly onto a CMOS imaging sensor.
- 3Pathological tissue sections from MGD patients and controls were rapidly analyzed, producing spectral feature maps in tens of milliseconds.
- 4The chip identifies MGD with 96.22% accuracy, outperforming conventional RGB image analysis (84%) and matching hyperspectral imaging.
- 5Distinct spectral signatures corresponded with disease severity and biochemical changes in gland tissue.
- 6The device is CMOS-fabricated, enabling potential clinical integration for real-time, objective ocular assessment.
Why It Matters
This innovation demonstrates the power of combining metasurface optics and AI for rapid, objective tissue diagnostics—reducing reliance on subjective clinical assessment and paving the way for real-time, in-sensor medical AI applications.
Source
EurekAlert
Related News
•EurekAlert
Researchers Develop All-Optical Synapse for Neuromorphic Imaging Systems
A new artificial synapse, controlled entirely by light, enables in-sensor neuromorphic processing for more efficient and noise-resistant imaging systems.
•EurekAlert
Mayo Clinic Showcases Imaging AI and Early Cancer Detection Advances at ASCO 2026
Mayo Clinic researchers will present over 30 studies at ASCO 2026, highlighting new advances in imaging AI, data science, and early cancer detection.
•EurekAlert
AI-Simulation Approach Achieves 90% Faster Brain MRI with Minimal Data
A simulation-based AI method can reconstruct brain MRI scans with only 10% of the usual data, greatly reducing scan times.